IFRX
InflaRx NV
NASDAQ · Healthcare · Biotechnology · DE
$1.37
−15.74%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-20.3%
Return on equity
-18.2%
Return on assets
-22.5%
Return on invested capital
-0.00x
Asset turnover
-$21.1M
Cash from operations
$0.87
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026